Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recombinant live virus vaccines.

M Mackett1

  • 1Paterson Institute for Cancer Research, Christie Hospital, Manchester, U.K.

Immunology Letters
|December 1, 1987
PubMed
Summary

Genetically engineered live attenuated vaccines, using vaccinia virus, express foreign antigens for protection. While promising for human use, challenges remain, but they are valuable research tools.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The live vector approach-viruses.

World journal of microbiology & biotechnology·2014
Same author

Manipulation of vaccinia virus vectors.

Methods in molecular biology (Clifton, N.J.)·2011
Same author

Comparative analysis of the expression of the Epstein-Barr virus (EBV) anti-apoptotic gene BHRF1 in nasopharyngeal carcinoma and EBV-related lymphoid diseases.

Journal of medical virology·2001
Same author

Transferrin receptor-mediated gene transfer to the corneal endothelium.

Transplantation·2001
Same author

Vaccinia expression of Mycobacterium tuberculosis-secreted proteins: tissue plasminogen activator signal sequence enhances expression and immunogenicity of M. tuberculosis Ag85.

Microbes and infection·2001
Same author

Heparin and heparan sulfate bind interleukin-10 and modulate its activity.

Blood·2000

Area of Science:

  • Vaccinology
  • Virology
  • Immunology

Background:

  • Live attenuated viruses are the basis for many successful vaccines.
  • Genetically engineering these vaccines to express antigens from other pathogens is a promising strategy.
  • Vaccinia virus, the smallpox vaccine, serves as a prototype for this approach.

Purpose of the Study:

  • To explore the potential of genetically engineered live attenuated vaccines expressing foreign antigens.
  • To review the development and application of vaccinia virus recombinants.
  • To assess the utility of these recombinants as laboratory tools and for potential human use.

Main Methods:

  • Review of existing literature on vaccinia virus recombinants.
  • Analysis of studies demonstrating protection in animal models.
  • Evaluation of vaccinia virus recombinants for dissecting immune responses.

Main Results:

  • Over one hundred vaccinia virus recombinants have been documented.
  • Many of these recombinants have shown efficacy in protecting animals against pathogens.
  • Vaccinia virus recombinants are valuable tools for studying cell-mediated and humoral immunity.

Conclusions:

  • Vaccinia virus recombinants show significant potential for vaccine development and immunological research.
  • Further research is needed to overcome challenges for human clinical application.
  • The use of these recombinants beyond experimental settings is yet to be determined.

Related Experiment Videos